Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.820
-0.240 (-5.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Grace Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 15.16 | 23.01 | 27.88 | 30.34 | 50.94 | 14.24 | Upgrade
|
| Short-Term Investments | 0.02 | - | 0.02 | 13.32 | 9.79 | - | Upgrade
|
| Cash & Short-Term Investments | 15.17 | 23.01 | 27.89 | 43.66 | 60.73 | 14.24 | Upgrade
|
| Cash Growth | -43.83% | -17.52% | -36.12% | -28.11% | 326.48% | -44.72% | Upgrade
|
| Other Receivables | 0.42 | 0.72 | 0.8 | 0.55 | 0.53 | 0.55 | Upgrade
|
| Receivables | 0.42 | 0.72 | 0.8 | 0.55 | 0.53 | 0.55 | Upgrade
|
| Prepaid Expenses | 0.48 | 0.28 | 0.6 | 0.72 | 0.34 | 0.98 | Upgrade
|
| Other Current Assets | - | - | - | 0.35 | 0.77 | 2.7 | Upgrade
|
| Total Current Assets | 16.06 | 24.01 | 29.29 | 45.28 | 62.37 | 18.46 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.01 | 0.57 | 0.57 | 0.09 | 0.15 | Upgrade
|
| Goodwill | 8.14 | 8.14 | 8.14 | 12.96 | - | - | Upgrade
|
| Other Intangible Assets | 41.13 | 41.15 | 41.13 | 69.81 | - | 4.24 | Upgrade
|
| Total Assets | 65.35 | 73.3 | 79.12 | 128.62 | 62.46 | 22.85 | Upgrade
|
| Accounts Payable | 1.68 | 1.01 | 1.24 | 1.68 | 0.12 | 1.71 | Upgrade
|
| Accrued Expenses | 1 | 0.68 | 2.09 | 1.48 | 1.38 | 5.61 | Upgrade
|
| Current Portion of Leases | - | - | 0.08 | 0.1 | 0.09 | 0.08 | Upgrade
|
| Total Current Liabilities | 2.67 | 1.68 | 3.41 | 3.26 | 1.58 | 7.4 | Upgrade
|
| Long-Term Leases | - | - | 0.41 | 0.19 | - | 0.07 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.94 | 5.51 | 7.35 | 16.89 | - | - | Upgrade
|
| Other Long-Term Liabilities | 2.6 | 4.36 | - | 0.01 | 5.22 | 2.39 | Upgrade
|
| Total Liabilities | 9.22 | 11.56 | 11.17 | 20.35 | 6.8 | 9.86 | Upgrade
|
| Common Stock | 261.04 | 261.04 | 258.29 | 257.99 | 197.19 | 137.42 | Upgrade
|
| Additional Paid-In Capital | 18.3 | 17.86 | 13.97 | 12.15 | 10.82 | 9.8 | Upgrade
|
| Retained Earnings | -217.17 | -211.12 | -198.27 | -155.84 | -146.02 | -126.34 | Upgrade
|
| Comprehensive Income & Other | -6.04 | -6.04 | -6.04 | -6.04 | -6.33 | -7.89 | Upgrade
|
| Shareholders' Equity | 56.13 | 61.74 | 67.96 | 108.27 | 55.66 | 12.99 | Upgrade
|
| Total Liabilities & Equity | 65.35 | 73.3 | 79.12 | 128.62 | 62.46 | 22.85 | Upgrade
|
| Total Debt | - | - | 0.49 | 0.3 | 0.09 | 0.15 | Upgrade
|
| Net Cash (Debt) | 15.17 | 23.01 | 27.41 | 43.37 | 60.65 | 14.09 | Upgrade
|
| Net Cash Growth | -43.73% | -16.06% | -36.81% | -28.49% | 330.32% | -42.28% | Upgrade
|
| Net Cash Per Share | 1.32 | 2.41 | 3.69 | 7.06 | 24.54 | 8.00 | Upgrade
|
| Filing Date Shares Outstanding | 10.14 | 9.4 | 7.44 | 7.38 | 4.34 | 1.93 | Upgrade
|
| Total Common Shares Outstanding | 10.14 | 9.4 | 7.44 | 7.38 | 4.34 | 1.88 | Upgrade
|
| Working Capital | 13.39 | 22.33 | 25.88 | 42.02 | 60.79 | 11.07 | Upgrade
|
| Book Value Per Share | 5.54 | 6.57 | 9.14 | 14.67 | 12.82 | 6.91 | Upgrade
|
| Tangible Book Value | 6.87 | 12.46 | 18.69 | 25.5 | 55.66 | 8.75 | Upgrade
|
| Tangible Book Value Per Share | 0.68 | 1.33 | 2.51 | 3.45 | 12.82 | 4.66 | Upgrade
|
| Machinery | - | 0.61 | 0.67 | 0.7 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.